Products

Online Inquiry

Name*

Phone

Email*

Services or Products of Interest*

Project Description

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Pramiracetam

INQUIRY

CAT. NO.: ABA-095

Product Details
CAS Number	68497-62-1
Appearance	White crystalline powder
Purity	0.99
Alternate Name	N-(2-(Bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide
Molecular Formula	C₁₄H₂₇N₃O₂
Molecular Weight	269.38
SMILES	O=C(NCCN(C(C)C)C(C)C)CN1C(CCC1)=O
Storage Conditions	Keep in cool & dry place.

Description
Pramiracetam is an analogue of piracetam, chemical name: N-(2-(bis(isopropylamino)ethyl)-2-oxo-1-pyrrolidine acetamide, is a new pyrrolidone-based brain function improver, indicated for the treatment of memory and recognition impairment, language impairment . Treatment and prevention of Alzheimer's disease (Alzheimer's disease). Pramiracetam, a pyrrolidone-based brain metabolism improver, is a central nervous system drug that improves memory and anti-amnesia, developed by Parke-Davis Pharmaceuticals, Inc. in the U.S. It has a strong ability to improve brain function, enhance memory and promote brain acuity. Clinical trials have demonstrated that pramiracetam is 6-13 times more active than piracetam (brain rejuvenation), 3-4 times more active than olacetam, and 1.25 times more active than anisiracetam, with low toxicity and good tolerability for long-term use to improve symptoms and delay Alzheimer's type dementia.

Description

Pramiracetam is an analogue of piracetam, chemical name: N-(2-(bis(isopropylamino)ethyl)-2-oxo-1-pyrrolidine acetamide, is a new pyrrolidone-based brain function improver, indicated for the treatment of memory and recognition impairment, language impairment . Treatment and prevention of Alzheimer's disease (Alzheimer's disease).
Pramiracetam, a pyrrolidone-based brain metabolism improver, is a central nervous system drug that improves memory and anti-amnesia, developed by Parke-Davis Pharmaceuticals, Inc. in the U.S. It has a strong ability to improve brain function, enhance memory and promote brain acuity.
Clinical trials have demonstrated that pramiracetam is 6-13 times more active than piracetam (brain rejuvenation), 3-4 times more active than olacetam, and 1.25 times more active than anisiracetam, with low toxicity and good tolerability for long-term use to improve symptoms and delay Alzheimer's type dementia.

Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.